Biological therapies in breast cancer: Common toxicities and management strategies. The breast, Vol. 22(6), p.1009-18.
Barrouso-Sousa, R., et al.
http://www.thebreastonline.com/article/S0960-9776(13)00262-2/abstract?rss=yes
In recent years, a number of new molecules – commonly known as biological therapies – have been approved or are in late stages of regulatory evaluation for the treatment of advanced breast cancer. These innovative compounds have improved treatment efficacy and have probably contributed to the increase in survival length observed in some breast cancer subtypes.
